Visx CustomVue
This article was originally published in The Gray Sheet
Executive Summary
Wavefront-guided custom ablation laser correction system will compete head-to-head with Alcon Lab's CustomCornea system, following FDA PMA approval announced May 23. Alcon has been alone on the U.S. market with a custom ablation system since FDA approval in October 2002. Separately, Visx shareholders elect Visx-backed board of directors and rejected largest shareholder Carl Icahn's candidate Keith Meister...